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ApoptosisMitochondria are pivotal for cellular bioenergetics, but are also a core component of the cell death machinery.
Hypothesis-driven research approaches have greatly advanced our understanding of the role of mitochondria
in cell death and cell survival, but traditionally focus on a single gene or specific signalling pathway at a time.
Predictions originating from these approaches become limited when signalling pathways show increased
complexity and invariably include redundancies, feedback loops, anisotropies or compartmentalisation. By
introducing methods from theoretical chemistry, control theory, and biophysics, computational models have
provided new quantitative insights into cell decision processes and have led to an increased understanding of
the key regulatory principles of apoptosis. In this review, we describe the currently applied modelling
approaches, discuss the suitability of different modelling techniques, and evaluate their contribution to the
understanding of the mitochondrial apoptosis pathway. This article is part of a Special Issue entitled
Mitochondria: the deadly organelle.ondria: the deadly organelle.
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With recent advances in biochemistry, molecular biology and
imaging, a large volume of detailed experimental data has accumu-
lated that has contributed towards our understanding of complex
cellular pathways such as apoptosis. Yet, a better understanding of the
molecular machinery also requires a broadening of the conceptual
arsenal that puts these data into an interpretative context. While
graphical schemes and flow charts are commonly used to relate basic
experimental findings to each other and to establish cause–effect
relationships, approaches that manage complexity, identify regulato-
ry steps and assess the timing and the quantitative contribution of
concurring signalling pathways are needed.
Systems biology combines computational approaches with wet lab
experiments to addresses these challenges. This short review is
dedicated to describing the various mathematical and computational
systems approaches that attempt to address this issue in the field of
mitochondrial apoptosis. We firstly give some practical hints for model
generation and development in biochemistry and advocate the benefits
of applying suchmodels to experimental data.We then examine several
modelling approaches, discuss their mathematical framework, suitabil-
ity and limitations, and reviewhowtheyhavebeen applied todata in the
literature. We start with a brief paragraph on Ordinary DifferentialEquations (ODE), which extends on concepts such as mass action
kinetics that are familiar to a biochemistry audience. We expand this to
includediffusion and spatial anisotropies, anddiscuss PartialDifferential
Equations (PDE) and Cellular Automata. We then give a short review
over the more abstract logical (Boolean) models, and conclude by
exemplifying the benefits of computational models using a recently
developed cellular automaton model that discriminates between two
concurrent hypotheses of BH3-only protein interaction during mito-
chondrial outer membrane permeabilisation.
2. Establishment of a systems biology model
Wepresent here a guide to readers as tohowa systemsbiologymodel
is developed, what is achievable during its development and where
research needs to focus to improve its utility in describing and explaining
existing data or predictingnewbiological effects. Systemsbiologymodels
are often best developed by close interaction between wet lab and in-
silico researchers, as demonstrated in the field of apoptosis [1–10]. At
each step of development, newbiological information has to be acquired,
but also new – often surprising – insights can be gained.
Model development (Fig. 1) starts with the definition of the model's
research question. This is followed by assembly of a descriptive model
that summarises the studied biological process in a structured and
comprehensive form by intensive screening of the respective literature.
The research question and model scope are decided, detailed and
formalised by designing the model's minimal requirements: 1) a model
input reflecting the causative nature of processes. Typical inputs are
stress stimuli, pharmacological treatments, or geneticmanipulations;2)a
model output,whichmaybeexperimental results, suchas theoccurrence
of cell death or apoptosis, the effectiveness of a treatment, or phenotypes
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Fig. 1. A workflow for model development. A classification of models according to the maturity of their development is given. Necessary steps that should be performed during each
development phase and potential benefits that can be gained are listed. Descriptive models summarise and formalise a research question in a coherent scheme. During refinement
and experimental validations, models become explanatory. Explanatory models remodel cause–effect relationships either qualitatively or quantitatively and allow assessment of the
accuracy of the assumed biological processes and the chosen model parameters. Predictive models help to identify new regulators and thereby suggest new qualitative or
quantitative hypotheses. Once validated, an iterative cycle of predictions, validations and model extensions can be performed to achieve a broader and more detailed description of
the process under study.
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network of intermediaries such as ions, genes, proteins, metabolites,
pharmacophores, systems pathways, tissues, or even organs; and 4) a
process that mediates this signalling. This process can be a logical or
statistical link, or a defined kinetic such as mass action (where reaction
rates are assumed proportional to the product of concentrations of
involved entities). Taking this approach, the requirement to provide a
complete and detailed picture often directs the researcher's attention
towards entities or interactions that would have been neglected in
reductionist approaches. An appropriate modelling technique is chosen
next by considering the quantity and quality of available data, the
required computational effort, and the research question (see discussion
of strengths andweaknesses in the respectivemodelling sections below).
In a critical validation step, certain model entities, interactions, or
pathway branches are frequently required to be disregarded by in-silico
researchers in order to decrease complexity, and identify primary vs.
secondary pathways. Likewise, strengths and weaknesses of competing
theories can be critically assessed. In this regard, an interactionwithwet-
laboratory-based researchers is particularly important.
At the next level, an explanatory model is developed which first
should be capable of describing causal, qualitative biological relation-
ships. A relevant example for cell death research is the process of Bax
oligomerisation as a consequence of its translocation, conformational
activation, and dissociation from pro-survival proteins. Nevertheless,
failure to accurately describe such a relationship is often valuable
feedback for experimentalists and modellers, indicating that either our
understanding of the underlying biological process is incomplete, or
essential components were disregarded by the model. Basic stability
considerations can be applied already at this stage, by evaluating
whether themodelwould predict tolerance to sub-threshold activation.
Quantitative modelling of experimental data should be imple-
mented next. Initially, this is achieved through ‘re-modelling’ rather
than ‘modelling’. Re-modelling of experimentally generated data
provides important insights into the correctness of the assumed
pathway topology and time scales. Experimental data may be
integrated on a single-cell or population level. Single-cell data are
beneficial when a model needs to accurately study the temporal
relationship between intracellular signalling events, and whenever
there is a heterogeneous response to an input across the population.
Population data may be sufficient for a rough quantification of cause–effect relationships (e.g. changes of % cell death to changes of
signalling protein expressions), yet there is no steadfast rule with
regards to the quality of data that is needed.
At the mature, predictive level a model is capable of identifying
new regulators and to qualitatively and quantitatively generate novel
hypotheses. These hypotheses can be validated by purpose-built
experiments which often challenge creativity of the experimentalist,
and can result in novel experimental set-ups and may give even
further unexpected insights. Finally, the model can be improved by
starting an iterative cycle of model prediction, experimental feedback,
and model refinement.
The above scheme is intended to motivate and guide model
development for any experimental researcher considering the use of
systems approaches. However, certain important limitations need to be
emphasised.Although crudemodelling is in principal possiblewhenever
the above minimal requirements are fulfilled, not all models can be
developed or are required to achieve full maturity. Depending on the
research question or the researcher's strategy, a qualitative explanatory
model may for example suffice to illustrate new experimental findings.
Likewise, the lack of experimentally accessible data (protein levels,
kinetic/rate constants, pathway details) often precludes the full model
development to quantitative or predictive levels. In addition, the
classification in the scheme rather refers to particular model aspects
than to themodel as awhole. As anexample, amodelmayquantitatively
correctly describe the transcriptional response to apoptotic stress,
butmayportray apoptosis execution only in a qualitativeway. Therefore
a classification of existing models remains rather subjective and we
refrained from applying it to the subsequently discussed approaches.
3. Modelling signal transduction by ordinary differential
equations (ODEs)
The generation of kinetic models of signal transduction pathways is
possible for processes that are relatively well understood and for which
sufficient biochemical data exist. An example of such a pathway is the
caspase activation cascade. Such modelling approaches have been
proven to behighly effectivewhen combinedwith single-cell (e.g. time-
lapse microscopy) [1,2,4,5,7–12] or population-based (e.g. quantitative
Western blotting or flow cytometry) experiments [1,3,6,7,13,14].
However, pure theoretical studies have also been fruitful and are
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mostly apply sets of ordinary differential equations (ODEs) to generate
protein profiles over time. Their design [27–29] requires a given
topological network of protein interactions, assumed interaction
kinetics between proteins or subsystems (such as mass action,
Michaelis–Menten, or Hill kinetics), parameters that quantify the
strength and speed of this particular kinetic, as well as initial protein
concentrations. The four standard types of interactions that are usually
considered in the study of apoptotic signal transduction [27–29] are
Irreversible cleavage R1 : A + C→A′ + Fragments + C
Binding Inhibitionð Þ R2 : A + 2B↔AB2
Degradation R3 : A′→K
Synthesis & Degradation R4 : K→B
ð1Þ
as exemplified here for the proteins A, B, C, A′ and the heterotrimer
AB2. Typically, the first reaction (R1) describes an enzymatic cleavage
reaction with C representing the enzyme, A the substrate (which may
be an inactive proform), and A′ the product (which may be the active
version of the protein). Fragments (here originating from cleavage of
A to A′) that have no further impact on the signalling cascade are
frequently disregarded. The second interaction (R2) is a reversible
reaction. It mimics an equilibrium between association and dissoci-
ation of the protein A with two proteins B, and is often employed
when modelling inhibitions (such as the interaction between pro-
survival and pro-apoptotic Bcl-2 family members). The latter two
processes (R3 and R4) describe interactions that are more abstract
than the former. The protein degradation (R3) usually considers the
complex biochemical machinery of proteasomal and/or lysosomal
degradation, while R4 additionally includes protein synthesis as a
consequence of gene induction and protein translation.
Under the assumption of mass action kinetics, the rate of reaction
over time is proportional to the concentrations of substrates, enzymes
and products involved. Thus:
v1 = k
cleave
1 ⁎ A½ ⁎ C½ 
v2 = k
ass
2 ⁎ A½ ⁎ B½ 2−kdiss2 ⁎ AB2½ 
ð2Þ
with v1 and v2 the reaction rates related to R1 and R2 respectively, and
the brackets denoting the concentrations of enzyme [A], product [A′],
substrate [C], binding protein [B] or heterotrimer [AB2]. In the second
reaction, the bi-directionality is rendered by balancing forward and
backward reactions, and the stoichiometry of the protein B is given by
the square in the first term. The rate (kinetic) constants for binding
(k2ass), dissociation (k2diss) and cleavage (k1cleave) are specific for each
reaction, butmay differ under different physiological conditions such as
temperature, pH or composition of the extracellular medium. For
example, the interaction of Bcl-2 family proteins and Bax/Bak-induced
pore formation may be dramatically altered within a lipid environment
[30,31]. Rate constants may be found in literature [1,3,12] and in
databases [32]. They are often derived from in vitro experiments of cell
extracts [33–35] or from purified proteins using the BIAcore technology
[36]. Often certain rate constants cannot be found, nor determined by
experiments at all. In these cases, they need to be adapted through the
process of ‘model training’. With this approach, we assume a known
output (e.g. by using results from a set of control experiments) and
adapt themodel parameter accordingly. This approachworkswellwhen
few parameters need to be optimised, but otherwise may result in sub-
optimal or ambiguous solutions [3,37].
The degradation reaction R3 can be described as
v3 =
d A′½ 
dt
= −kdeg3 ⁎ A′
  ð3Þ
where the reaction rate v3 (the loss of protein per unit time d[A′]/dt)
is proportional to the available protein quantity and is equivalent to afirst order chemical reaction with the proportional factor k3deg. In case
of endogenous proteins, a state of equilibrium between transcription/
translation and degradation is reached (Reaction R4, protein B). We
therefore write
v4 =
d B½ 
dt
= kprod4 −k
deg
4 ⁎ B½  ð4Þ
as a sum of production and degradation terms, with respective
parameters k4prod and k4deg. The equilibrium condition d[B]/dt=0 leads
to a concentration B0=k4prod/k4deg that would occur if this process had
no further interactions.
Finally, the rates of changes in each protein are mediated from the
contribution of each reaction. We finally get
d A½ 
dt
= −v1−v2 = −k
cleave
1 ⁎ A½ ⁎ C½ −kass2 ⁎ A½ ⁎ B½ 2 + kdiss2 ⁎ AB2½ 
d A′½ 
dt
= v1−v3 = k
cleave
1 ⁎ A½ ⁎ C½ −kdeg3 ⁎ A′½ 
d B½ 
dt
= −2v2 + v4 = −2k
ass
2 ⁎ A½ ⁎ B½ 2 + 2kdiss2 ⁎ AB2½  + kprod4 −kdeg4 ⁎ B½ 
d AB2½ 
dt
= + v2 = k
ass
2 ⁎ A½ ⁎ B½ 2−kdiss2 ⁎ AB2½ 
d C½ 
dt
= 0⇒ C½  = const:
ð5Þ
Eq. (5) is a typical system of coupled ODEs and can be solved
numerically. Evaluating the solution requires appropriate initial
protein levels for (A(0), A′(0), B(0),AB2(0), C(0)). These are specific
for each cell system and rarely available in literature or public
databases [38]. They can be experimentally obtained by comparing
cell extracts to purified proteins [9] or to relative quantifications
versus other cell lines [28] which have known absolute levels.
Whenever the derivatives on the left hand side of an ODE network
are all zero (as in Eq. (5)), concentrations do not change over time and
a steady state is reached. Initial survival conditions and executed
apoptosis are typical examples thereof. A steady state that is
insensitive to small perturbations (where perturbations will be
equalised over time) is denoted as locally stable. A protocol for
analysing local stability is given in [19].
4. ODE-based models of the mitochondrial apoptosis pathway
Non-linear, ODE-based mathematical models have contributed
significantly to the field of apoptosis research by providing compre-
hensive explanations for experimentally observed phenomena. These
include the rapidity of effector caspase activation subsequent to
mitochondrial outer membrane permeabilisation (MOMP), states of
sub-lethal caspase activation, and switches between type 1 (not
requiring mitochondrial signal amplification) and type 2 apoptosis
(requiring mitochondrial amplification) during death receptor acti-
vation. ODE-based modelling was introduced to studies in apoptosis
by Fussenegger and co-workers a decade ago [39] in a theoretical
study of the stress-induced mitochondrial apoptosis pathway and
death receptor-induced extrinsic apoptosis. MOMP-induced cyto-
chrome-c release served as a mediator of stress-induced disequilib-
rium between pro-survival and pro-apoptotic Bcl-2 family members.
Despite the fact that the authors relied on ad hoc fixing of kinetic
parameters, they were able to model a temporal evolution of caspase
activation which was dependent on the intracellular Bcl-2 level. The
authors also provided explanations of caspase inhibition and delayed
apoptosis in p53 mutant cell lines or in response to XIAP over-
expression. In a subsequent study, Eissing et al. [19] focused on the
extrinsic apoptosis pathway of caspase activation. Although themodel
was designed to bypass any engagement of mitochondria, it was
Bcl-2
Bcl-xl
Bcl-w
Mcl-1 BaxBak
BidBimPuma
Bad Bmf Noxa
Bcl-2 family members
Multi-domain /
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Fig. 2. Bcl-2 Family members. Proteins of the Bcl-2-family that govern cell fate and lead
to MOMP. Pro-survival proteins (shown here within the green section) inhibit pro-
apoptotic proteins (pink coloured section, inhibition symbolised by parallel lines). BH3-
only proteins (red section) competitively bind to pro-survival proteins (solid parallel
lines), thereby de-repressing themultidomain pro-apoptotic proteins (rose section; de-
repression visualised by the solid lever bar) that can form pores into the outer
mitochondrial membrane. In the direct activation model, distinct BH3-only proteins
(Activators, red brown section) additionally enzymatically activate multidomain pro-
apoptotic proteins (black arrows) while Enabler (orange section) are confined to their
de-repression role.
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apoptotic signal transduction (see discussions below), and could
remodel the fast kinetics of caspase-3 activation that were reported
for death receptor-induced apoptosis in single-cell studies [40,41].
Pace et al. [42] revisited this model and experimentally confirmed
predictions linking reduction in levels of the procaspase-8 inhibitor
BAR to accelerated caspase-3 activation.
Stucki and Simon [23] were the first to model the effect of
mitochondrial cytochrome-c and Smac release on caspase activation.
In this theoretical study, death receptor activation was modelled to
lead to a dose-dependent cytochrome-c release which increased the
concentration of active caspase-3 inversely to the level of the
endogenous caspase-3 inhibitor, XIAP. Internal signals were modelled
to trigger a dose-dependent Smac release which was antagonised by
the proposed Smac inhibitor Survivin. As both pro-apoptotic mechan-
isms are restrained by apoptosis repressors, the modelling approach
could achieve stability against mild and accidental caspase-3
activation. Clearly, the general concept that the strength of apoptosis
activators in balance to their repressors provides a safeguard towards
accidental apoptosis activation is justified. However, the notion of a
dose-dependent MOMP that triggers different levels of caspase-3
activation is questionable. Cytochrome-c [43] and Smac release [44]
have been shown to occur as rapid, complete and one step processes
with weak dependence of their kinetics on stimulus and dose
[10,43,45]. Likewise, cytochrome-c only binds to the apoptosome
transiently and therefore even if concentrations were low, a rate-
limiting effect on caspase-3 activation seems unlikely [46].
In a study that combined quantitative Western blotting experi-
ments with ODE modelling, Bentele, Lavrik and colleagues provided a
structured model of CD95/Apo-1-induced extrinsic apoptosis [3,6].
Mitochondrial cell death processeswere initiated upon surpassing of a
threshold concentration of truncated Bid (tBID) and as a result of
CD95/Apo-1-induced caspase-8 activity. Model topology, including
kinetic parameters, was assembled through a critical and extensive
screen of literature and databases. To address the problem of
complexity in their original model (which included approximately
70 molecules, 80 reactions and more than 120 parameters) the
authors structured models into subsystems on the basis of different
information parameters. These included both subsystems for which
sufficient data was available for detailed mechanistic descriptions,
and subsystems (including mitochondria and the process of MOMP)
which, in the absence of detailed mechanisms, were modelled as
‘black-boxes’with an input–output behaviour trained to experimental
data. Importantly, the authors combined modelling and experimental
validation, introduced sensitivity and robustness analysis to the field,
and identified a threshold mechanism for the regulation of the
extrinsic apoptosis pathway (in particular the expression levels of c-
FLIP). The authors recently expanded their model to study NF-κB
activation in CD95-dependent apoptosis [7], and provided evidence
for a role of p43-FLIP as an IKK activator.
In 2006, Rehm, Huber and co-workers presented a study which for
the first time combined single-cell imaging of caspase activation with
ODE-based pathway modelling to obtain insight into the signalling
cascade of the mitochondrial apoptosis pathway which was both
qualitative and quantitative [9]. Themodel assumed that cytochrome-
c induced apoptosome formation and Smac release were triggers for
the mitochondrial apoptosis pathway. Model predictions were
validated using fluorescence microscopy which detected the cleavage
of a caspase-3-specific FRET probe in relation to mitochondrial
membrane potential depolarisation (which served as an indicator of
MOMP). The ODE-based approach could successfully remodel the
FRET probe cleavage kinetics of HeLa cells exposed to pro-apoptotic
stimuli (such as staurosporine), and predicted a significantly delayed
and suboptimal cleavage of cellular substrates after XIAP over-
expression or caspase-3 deletion. This was experimentally validated
in subsequent single-cell imaging studies. The approach was revisitedin a study by O'Connor and co-workers, in which this systems model
gave insights into the acceleration of apoptosis in XIAP-deficient
HCT116 and DLD colon cancer cell lines [8].
While the studies described above focused largely on the effect of
MOMP-induced release of cytochrome-c and Smac on caspase
activation, the mechanisms and mathematical modelling of MOMP
formation remained more challenging. MOMP is often considered to
be pivotal during stress-induced apoptosis [47]. MOMP integrates
stress and survival signalling by the interaction of pro-survival and
pro-apoptotic members of the Bcl-2 protein family [48]. The principle
members of this family are shown in Fig. 2. The multidomain Bcl-2
family member proteins Bak and Bax homo-oligomerise and form
pores in the mitochondrial outer membrane [49]. Their functionality
is attenuated by the interplay of two further classes of Bcl-2 family
members, the pro-apoptotic BH3-only proteins and pro-survival
members (Bcl-2, Bcl-w, Bcl-xl, Mcl-1). This signalling cascade is also
of importance for death receptor-induced apoptosis where caspase-
8 cleaves and activates the BH3-only protein Bid. Truncated Bid (tBid)
leads to MOMP in a Bax/Bak-dependent manner and therefore links
the extrinsic to the intrinsic apoptosis pathway.
Albeck et al. [1,2] combined live-cell imaging of caspase activation
and MOMP, flow cytometry, immunoblotting and systems modelling
of HeLa cells exposed to the death receptor agonist TRAIL. They
experimentally characterised a long-lived cellular state prior to, or in
the absence of, MOMP after the treatment with TRAIL. The state was
characterised by active initiator (caspase 8) and effector caspases, yet
without detectable cleavage of cellular substrate. For a mechanistic
investigation, they devised a computational model. It comprised
activation of effector caspases by initiator caspases, and in addition
included feedback from active caspase-3 to caspase-8 via caspase-6.
They further included MOMP induction by activation of pro-apoptotic
multidomain proteins (Bak/Bax/Bok) by tBid, whose activation was
attenuated by pro-survival Bcl-2members. For simplification, all Bcl-2
pro-survival proteins were considered as one model variable. When
Bcl-2 levels were set sufficiently high to block MOMP, the model
rendered a meta-stable state, with initiator (but not effector) caspase
activity. This occurred as a consequence of inhibition of effector
caspases by XIAP and also caspase degradation by the proteasome,
with the latter partially dependent on XIAP acting as an E3-ligase.
When this stabilisation was abolished by assuming low levels of XIAP
or by inhibition of effector caspase degradation, their model predicted
mild effector caspase activity. This suggested that if cleavage of
cellular substrates was submaximal, the cell would not commit to
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presence of the proteasome inhibitor MG132 or by XIAP silencing, the
existence of such a state was confirmed in Bcl-2-overexpressing,
MOMP-resistant HeLa cells. When MOMP was re-established by
reducing Bcl-2 levels or increasing pro-apoptotic BH3-only members,
a more potent activation of caspases was predicted by the model and
this was validated in wild-type HeLa cells exposed to TRAIL.
In a theoretical study, Zhang and co-workers [25] established a
comprehensive model of how intrinsic stress proceeds to MOMP and
caspase activation. Their approach consisted of apoptosis initiation,
amplification and execution modules that together guarantee cellular
robustness to sub-threshold stimuli. To simplify their model and in
accordance with other approaches [1,4,17,18] the authors did not
differentiate between particular members of the pro-survival and the
pro-apoptotic Bcl-2 group, including BH3-only proteins. As genotoxic
stress [50–52], serum deprivation [53], or receptor-mediated stress
[54] each activate a unique subset of BH3-only proteins which
specifically interact with their pro-survival counterparts [55], an
extension of the model to include these stress-specific regulations
would be a desirable next step.
Finally, several purely theoretical approaches have investigated
bistability and robustness. Robustness tests the firmness of the model
results againstparameter variations. Theyalso examine the stability of the
survival steady state against accidental perturbations, a property
observed in biological systems. Bistability assumes a rapid switch
between two steady states (apoptosis and survival) without any stable
intermediary state that would indicate an ill-defined commitment to
apoptosis. Analyses can be performed using a defined mathematical
protocol [19] or employing tools for bistability analyses [56,57]. Eissing et
al. [33] studied robustness against zymogene protease activity, and
proposed inhibitor ultra-sensitivity or saturation effects as requisite for a
bistable system [58]. Legewie et al. [21] proposed two positive feedback
loops to guarantee bistability subsequent to the process of MOMP, while
Bagci et al. [15] discussed co-operativity in APAF-1 oligomerisation.
5. Spatial modelling approaches using Partial Differential
Equations (PDEs)
While the above ODE-based modelling approaches greatly ad-
vanced our understanding of cell survival and cell death regulation,
several key aspects of apoptosis signalling require further mechanistic
explanation. One such aspect is the rapidity and completeness of
mitochondrial cytochrome-c and Smac release subsequent to MOMP
that has been experimentally observed in several studies
[40,41,43,44,59]. Another important aspect that requires mechanistic
explanation is the concept of non-lethal caspase activation. Spatially
confined, non-lethal apoptosis has been observed in neuronal
development [60,61], long term potentiation [62,63], neuropatholo-
gies [64,65], and during cell differentiation [66–68].
ODE-based approaches rely on an isotropic distribution of reaction
partners in the signalling cascade. The process of diffusion therefore
limits ODE-based mathematical approaches. Diffusion may become a
rate-limiting process when apoptosis signalling occurs in large cells
such as neurons or myotubes. Diffusion processes are also relevant
when local anisotropies are likely to occur. Such anisotropies may
include spatial patterns of caspase-activating supra-structures, mito-
chondria and proteolytic machineries.
To account for diffusion, above ODE-based framework (Eq. (5))
needs to be extended. For simplicity, we will restrict ourselves to the
upper cleavage reaction in Eq. (1) and to a one-dimensional problem,
thus all proteins dependent on space x and time t.When freely diffusing,
A(x,t) obeys Fick's second law for non-steady state diffusion [69]
∂
∂t A x; tð Þ½  = D
∂2
∂x2
A x; tð Þ½ ; ð6Þwith ∂ indicating the partial derivatives with respect to space and
time. The diffusion constant D is an intrinsic protein property.
Assuming validity of the Stokes–Einstein relation (i.e., where the
diffusion constant is indirectly proportional to the cubic square root of
the mass) it can be calculated from its mass (massProtein) and the
reference diffusion constant DGFP=24 μm2s−1 [70] of the 27 kDa
(massGFP) GFP protein
Dn = DGFP⁎ massGFP =massprotein
 1=3
: ð7Þ
The total temporal changes of A(x,t) are given by adding-up
diffusion and biochemical interaction between A(x,t) and the protein
C(x,t) (Eq. (1)).
∂
∂t A x; tð Þ½  = D
∂2
∂x2
A x; tð Þ½  + kcleave1 ⁎ A x; tð Þ½ ⁎ C x; tð Þ½ : ð8Þ
Solution of the reaction–diffusion Eq. (8) needs appropriate
boundary conditions. When modelling for example the length of
cellular structure where signalling is propagated (for example a
neuronal axon or a myofiber) as x=L, we assume that no protein
transport is present at each end of the structure at all times, thus
∂
∂x cn x = 0; tð Þ = 0;
∂
∂x cn x = L; tð Þ = 0: ð9Þ
Eq. (8) can be easily extended to include a network of different
cleavage, inhibition, production and degradation reactions (see
Eq. (5)). Like ODEs, such one-dimensional PDEs can be easily solved
numerically. However, solution of 3D dimensional PDEs requires
techniques such as the Finite Element Methods [71] that are
mathematically and numerically much more sophisticated.
Rehm, Huber and co-workers were the first group to address
spatial signal propagation during apoptosis using mathematical
modelling [5,10]. By studying the spatial coordination of the onset
of MOMP induced by the extrinsic (using TRAIL) or mitochondrial
apoptosis pathway (using staurosporine) with high-speed live-cell
imaging [10], a spatial propagation of MOMP was experimentally
detected and mathematically remodelled using PDEs. By modelling a
spatial gradient in the generation of MOMP-inducing factors, the
experimentally detected signal was too slow to be explained by free
diffusion of the MOMP-inducer, and thus required the inclusion of
additional adsorption processes to remodel the biologically observed
kinetics. Stimulus-dependent velocity differences were explained by
different activation kinetics of MOMP-inducers. Importantly, the
study concluded 1) that the experimentally detected rapidity of
MOMP can be sufficiently explained by reaction–diffusion kinetics of a
MOMP-inducer (such as tBid); and 2) that the rate of synthesis of the
MOMP-inducer (rather than the threshold required for these proteins
to induce MOMP) is the key determinant of apoptosis activation.
In a follow-up study [5], the group also investigated the effects of a
spatial anisotropy in MOMP on caspase activation downstream of
MOMP. The authors employed a one-dimensional spatial version of
the previously described, ODE-based model of MOMP-induced
caspase activation that was based on Partial Differential Equations
(PDEs). They observed that a 10,000-fold impaired diffusivity was
required to maintain spatial anisotropies when assuming a Stokes–
Einsteinmotility of the entities, and that a relativelymodest reduction
in diffusability could suffice to maintain spatial gradients of caspase
activation when large entities (N500 kD) were considered immotile.
Clearly further studies employing spatial modelling approaches
combined with appropriate experimental techniques (such as
photo-activation and photo-bleaching) will shed light into spatial
aspects of MOMP induction and its downstream consequences.
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CellularAutomata are useful for studying protein networks under the
influence of stochastic fluctuations and spatial dependencies. Unlike 2D/
3D-PDE's, they are easy to solve bynumericalmeans (although this often
is quite time-consuming), and clearly outperform the latter if assuming
arbitrary cell shapes and/or anisotropies. For time-independent or
simple 1D-dependency, respectiveODEor PDE approaches are preferred
as they are computationally faster. Yet, due to theverydescriptivenature
of cellular processes (such as mimicking the cell or the mitochondrial
membrane as a lattice of compartments) they have gained popularity in
the systems biology field of apoptosis recently. In particular, they have
been applied in studies of the mitochondrial apoptosis pathway to
investigate and quantify the interactions of Bcl-2 family members at the
mitochondrial membrane, and to analyse the process of pore formation.
CA describe protein changes at discrete locations and time points, and
allow inclusionof stochastic events (i.e. the probability of events to occur
as a consequence of protein mobility) into the modelling approach. CA
approaches portray the dynamic behaviour of a system by dividing
spatial regimes into grids [72]. Protein representatives are distributed
over these grid points. Each protein is assigned a likelihood of diffusion.
Whenever this likelihood is larger than a step-specific random
number, it can diffuse to one of its neighbouring grids. Likewise, protein
reactions are possible, provided that they are co-located to the same
grid, connected via a reaction rule (Eq. (1)) and the assigned reaction
probability is higher than the above random number.
Application tomitochondrial apoptosiswas introducedby Siehset al.
[22] who studied the interaction of Bcl-2 family members at the
mitochondrial outer membrane. Chen et al. [17] later revisited this
approach to investigate bistability. While these two studies were
theoretical in nature, Duessmann et al. [4] used a CA approach to
remodel single-cell measurements of Bax translocation in relation to
MOMP induction, and to provide insights into the experimentally
observed fast pore formation kinetics (see their supplement for details).
The model input represented the stress-induced translocation of BH3-
only proteins and Bax proteins to the mitochondrial outer membrane.
These were deduced from quantitative confocal microscopy measure-
ments of YFP-Bax accumulation using confocalfluorescencemicroscopy
imaging in Bax- (and Bak-) deficient human cells. The mitochondrial
membrane was modelled by a two-dimensional, equally spaced grid of
100×100 compartments. Each grid element could contain a limited
number of proteins, and each protein was given a diffusion probability.
The direction of diffusion was arbitrary, although movements were
excluded when a container was fully occupied. Reactions were defined
by rules that linked one or a set of reaction partners to one or a set of
products. As a requirement, all necessary reaction partners needed to
co-locate on the samegrid. Analogous to kinetic constants inODE-basedFig. 3. Rapid onset of Bax pore formation modelled using Cellular Automata. Spatial and tem
following Bax translocation calculated with the direct activation model in Bak-deficient c
tb29 min after to onset of Bax translocation (first three images from left), active Bax was
significant Bax translocation, Bax homo-oligomerises to dimers (green squares), trimers anapproaches, the probability of occurrence of any specific reaction to
occur was assigned in an attempt to describe the dynamics of that
reaction on discrete time steps and allowing for stochastic fluctuations.
The formation of Bax or Bak tetramers, defined as sufficient to induce
pores [30], served as model output. An example of the spatial
distribution and temporal evolution of Bax oligomers and Bax bound
to pro-survival proteins remodelled from [4] is given in Fig. 3.
Several interesting conclusions could be drawn from this com-
bined single-cell imaging and mathematical re-modelling approach.
Firstly, only a small fraction of the cellular Bax pool appeared to be
required for MOMP (which was estimated to be less than 10% of the
total cytosolic Bax), and excess Bax translocation was occurring well
after MOMP. This observation was in agreement with similar studies
in isolated mitochondria or artificial biological membranes showing
that minimal amounts of pro-apoptotic Bcl-2 family members are
required to induce pore formation [73–75]. This also suggested that
excess Bax activation was central to guaranteeing the robustness of
the system towards perturbations of the signalling network. These
perturbations might arise through the accumulation of high levels of
anti-apoptotic Bcl-2 family members at (individual) mitochondrial
membranes. The second important conclusion from this studywas the
demonstration of sensitivity of the system. After an initial lag time
during which Bax molecules translocated to mitochondria, a sudden
and rapid increase in Bax tetramer pore formation was observed
(Fig. 3). This correlated well with the rapid release of cytochrome-c
which is observed experimentally during apoptosis.
7. Boolean and state based models
Models based on Boolean logic and state transitions are well suited
for larger networks where the comprehensiveness of the description or
the analysis of pathway topology is more important than the precise
quantitative behaviour. Model intermediaries (e.g. proteins) are
represented by pathway entities (called nodes) and their activities are
assigned to logical states. Each state is calculated from the states of all
connecting nodes using logical operations, similar to an electronic
circuit. Classically, two states (ON/OFF or activated/non-activated)
together with simple Boolean logic (AND/OR/NOT) are applied. Recent
methodological advances allow capturing the time dependency, the
inclusion of feedback loops and the addition of quantitative behaviour
[76–79].
In one of them, Schlatter et al. [79] provided a time-dependent and
multi-value node-logic Boolean network to investigate intrinsic and
extrinsic apoptosis and their cross-talk to survival pathways and
insulin signalling. Dynamic behaviour could be attained by starting
the simulation at different time points with certain protein interac-
tions only present at certain time intervals. Protein quantities wereporal distribution of Bax oligomers and active Bax dimerised to pro-survival proteins
ells. Reactions, parameters and translocation kinetics were taken from [4]. At times
inhibited by hetero-dimerisation with Bcl-2 (white squares with black edges). Upon
d pore-forming tertramers (red squares, right two panels).
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specific interactions (e.g. only high XIAP inhibits apoptosis). Their
network comprised 8 input nodes, 78 intermediaries and 125 interac-
tions andwas implemented in the software CellNetworkAnalyzer (CNA,
[80]). Input nodes were glucagon, insulin, TNF-α, Fas-Ligand, inter-
leukin1β, UV-irradiation and two further inputs to investigate SMAC-
mimetics that are drugs under clinical trial and sensitise cancer cells to
apoptosis. With their model and biochemical experience in mouse
hepatocytes they could effectively describe the dose-dependent effects
of UV-B irradiation on apoptosis.
Mai and Liu established amodel of extrinsic and intrinsic apoptosis
that included pro-survival signalling by growth factors via the PI3K/
AKT pathway as well as cross-talk between TNF-receptor signalling
and NFκB activation. They used two state (ON/OFF) and multiple time
step logic [77]. Node states were calculated from the input of all
connected nodes and additionally from its own state at the preceding
time step. A node is considered active upon the cumulative signal
exceeding a certain threshold. Mitochondrial apoptosis was modelled
as a result of TNF-receptor activation and triggered by the pro-
apoptotic BCL2-family members Bid (via caspase-8) or Bad (via RIP,
MAPK and p53). Caspase-3was activated in an apoptosome-dependent
and -independent (caspase-8) fashion and was attenuated by IAP and
AKT. By this model, they investigated the role of caspase-3-dependent
positive feedback loops under different TNF and survival signal inputs.
These loops were found to be essential for irreversible and robust
cell death commitment, yet they may partly compensate each other
to guarantee network plasticity when adapting to different cellular
environments.8. Outlook
As demonstrated by the different ODE, PDE, CA and Booleanmodels
presented in this review,mathematicalmodelling has been increasingly
used over the last years as a tool to explain complex biological
phenomena during apoptosis. This was only possible as a result of the
contribution of biochemical, genetic, and molecular research data by
numerous laboratories worldwide which have characterised the
signalling pathways involved. However, many aspects of apoptosis
signalling and cell fate decision making still remain unresolved.
Addressing such issueswith the two-pronged approach of experimental
data combinedwithmathematicalmodelling is likely tobe fruitful in the
future. However, modelling is frequently restricted by the extent and
quality of biochemical data available. An example given above is the
complex interaction of individual Bcl-2 family proteinmembers and the
current lack of biochemical data describing their behaviour in situ in
biologicalmembranes (rather than aqueous solutions). As a result, Bcl-2
family protein interactions have thus far beenmodelled using relatively
simplified approaches. With sufficient kinetic data available to describe
the individual interactions of Bcl-2 family proteins, mathematical
modelling will become an increasingly important tool to analyse the
complexity of Bcl-2 family member interactions and their integration
into stress-induced signalling pathways. Development of such stress-
specific models may aid for example in the prediction of therapeutic
effects of Bcl-2 antagonists or other apoptosis-sensitizing approaches
for the treatment of cancer.
Mathematical model are nowwidely used in nearly all fields of cell
signalling and cell physiology. Flux models in particular have been
widely applied in the field of bioenergetics and in the study of
mitochondrial physiology. However, the integration of mitochondrial
bioenergetics and apoptosis signalling is currently lacking, but has
the potential to provide novel mechanistic insights into cellular fate
decisions both upstream and downstream of MOMP, and to shed light
on the interrelation of bioenergetics, apoptosis, necrosis and autop-
hagy [81,82]. Single-cell sensors of bioenergetic state variables such as
respiration flux or cytosolic ATP that are necessary to validate suchmechanistic, ODE-based models have been recently developed
[81,82].
Finally, the translation of mathematical models into clinical
scenarios, and the ability of such models to predict clinical outcome in
response to therapy or to guide in individual treatment paradigms
remains as an area to be further explored and potentially utilised.
This will require the inclusion of genetic and epigenetic data into
mathematical models. Evidently, mathematical modelling will become
an increasingly important element in basic and translational biomedical
research.
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